Younger generations are facing a higher risk of cancer than their parents
www.scimex.org
Younger generations are facing a higher risk of cancer than their parents Each successive generation born during the second half of the 20th century has faced a higher risk of 17 cancers, according to a US study. The team looked at the incidence of 34 cancers and death rate of 25 for people

cross-posted from: https://lemmit.online/post/3567461

Younger generations are facing a higher risk of cancer than their parents. Each successive generation born during the second half of the 20th century has faced a higher risk of 17 cancers, accordi…

This is an automated archive made by the Lemmit Bot.

The original was posted on /r/science by /u/mvea on 2024-08-01 06:59:55+00:00.

Original Title: Younger generations are facing a higher risk of cancer than their parents. Each successive generation born during the second half of the 20th century has faced a higher risk of 17 cancers, according to a US study. 10 of these cancers are linked to obesity.

  • dirtybeerglass [none/use name]@hexbear.netEnglish
    11·
    3 months ago

    All that’s missing is a “thanks, boomers”

    Anyway, I obviously didn’t write this but :

    Cancer survival rates have improved significantly over the years, with considerable variations depending on the type of cancer. Here are some key statistics illustrating the overall improvements:

    1. Overall Cancer Survival: The 5-year relative survival rate for all cancers combined has increased from about 50% in the 1970s to around 67% for cancers diagnosed between 2011 and 2017.

    2. Specific Cancers:

      • Breast Cancer: The 5-year relative survival rate for localized breast cancer is now over 99%.
      • Prostate Cancer: The 5-year relative survival rate is nearly 98%.
      • Childhood Leukemia: The 5-year survival rate for acute lymphoblastic leukemia (ALL) in children is now about 90%.
      • Melanoma: The 5-year relative survival rate for localized melanoma is over 99%.

    3. Significant Gains: Some cancers have seen particularly dramatic improvements due to targeted therapies and early detection methods. For example, chronic myelogenous leukemia (CML) now has a 5-year survival rate of around 70%, up from less than 20% in the 1970s, largely due to the development of tyrosine kinase inhibitors.

    These improvements are a testament to the advances in medical research, treatment technologies, and early detection programs. However, survival rates can still vary widely based on factors such as the cancer type, stage at diagnosis, patient health, and access to care.

    • MeowZedong@lemmygrad.mlEnglish
      4·
      3 months ago

      I’m convinced the reason they only look at 5-year survival rates is because this drops precipitously after 5 years because they induced chemo resistance.

      Cancer is an evolutionary disease and we don’t treat it as such. In cases where a tumor isn’t immediately life threatening, it may be more helpful to maintain a treatment that only stops the growth of a tumor and maintains it at that level rather than nuking it from orbit. It would allow us to mitigate treatment resistance by rotating through therapeutics and have reduced side effects on the patient.

      If the typical chemo nuke doesn’t kill ALL of the cancer, it’s going to come back stronger. We have other models where we treat this way for evolutionary threats and it’s proven effective.